Charlie's Holdings, Inc.

Name: Charlie's Holdings, Inc. standardized financial statements, quarterly
Creator: Listed

CHUCOTCCIK 1134765HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$3.8m, Q2 FY2026

Operating income−$1.2m, Q2 FY2026

Net income−$1.7m, Q2 FY2026

Charlie's Holdings, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	2,706	5,544	3,051	2,043	1,624	1,047	1,578	1,761	7,084	8,982	4,804	3,802
Cost of revenue	$k	not reported	not reported	not reported	not reported	994	522	1,192	1,275	5,322	6,281	3,624	2,684
Gross profit	$k	not reported	not reported	not reported	not reported	630	525	386	486	1,762	2,701	1,180	1,118
Research and development	$k	41.0	37.0	6.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$k	(742)	99.0	(941)	(736)	(876)	(751)	(879)	(954)	(339)	(123)	(975)	(1,234)
Interest expense	$k	121	114	183	156	146	218	241	333	37.0	78.0	75.0	81.0
Income tax	$k	0.0	0.0	not reported	0.0	0.0	0.0	0.0	388	0.0	(151)	0.0	0.0
Net income	$k	(708)	(27.0)	(1,045)	(967)	(1,022)	(1,125)	(1,217)	4,961	624	131	(1,050)	(1,662)
Diluted EPS	$ per share	0.00	not reported	0.00	0.00	0.00	not reported	0.00	0.00	0.00	not reported	not reported	not reported
Basic EPS	$ per share	0.00	not reported	0.00	0.00	0.00	not reported	(0.01)	0.02	0.00	not reported	0.00	(0.01)

Balance sheet

Cash and equivalents$527.0k, Q2 FY2026

Long-term debt$3.1m, Q1 FY2025

Shareholders' equity$3.1m, Q2 FY2026

Charlie's Holdings, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.7	0.4	0.2	1.1	0.6	0.2	0.1	1.5	1.2	1.3	0.6	0.5
Current assets	$m	5.8	5.1	4.2	4.8	3.9	3.7	3.0	5.8	9.8	10.8	14.1	12.0
Total assets	$m	6.6	5.8	4.7	5.2	4.2	3.9	3.2	6.0	10.6	11.6	14.8	12.8
Current liabilities	$m	5.7	4.8	5.6	5.4	5.3	5.6	5.8	3.6	6.8	7.6	9.3	7.2
Total liabilities	$m	6.9	5.9	5.8	5.5	5.5	5.7	6.0	3.8	7.3	8.1	11.7	9.7
Long-term debt	$m	2.8	2.5	2.8	2.0	2.6	2.2	3.1	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	(0.2)	(0.1)	(1.1)	(0.3)	(1.3)	(1.8)	(2.8)	2.2	3.2	3.4	3.1	3.1

Cash flow

Operating cash flow−$383.0k, Q2 FY2026

Capital expenditure$0, Q4 FY2023

Charlie's Holdings, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(860)	(47.0)	(431)	131	(944)	(377)	(409)	(2,654)	(3,109)	394	(1,105)	(383)
Capital expenditure	$k	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Dividends paid	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)274.07m, Q2 FY2026

Charlie's Holdings, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	244	212	245	217	221	243	243	254	282	278	268	274

Shares outstanding: 280.55m at Aug 17, 2026, from the cover of the 10-Q filed Aug 17, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.